Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Sildenafil Citrate Orodispersible Tablets

Approval Number

国药准字H20249739

Company金鸿药业股份有限公司拱北分公司

Registration Date

December 17, 2024

Drug Information

Generic Name

枸橼酸西地那非口崩片

Dosage Form

片剂

Strength

50mg（按C₂₂H₃₀N₆O₄S计）

Drug Type

化学药品

Registration Date

December 17, 2024

Company Information

Applicant Company

Company Name金鸿药业股份有限公司拱北分公司

Company Address

珠海市金海岸生物工业区

Manufacturing Company

Company Name金鸿药业股份有限公司拱北分公司

Company Address

珠海市金湾区黄竹路268号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy